Kim Rivers Sells 137,535 Shares of Trulieve Cannabis (NYSE:TRLV) Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 137,535 shares of the company’s stock in a transaction on Wednesday, June 17th. The stock was sold at an average price of $9.36, for a total transaction of $1,287,327.60. Following the completion of the transaction, the chief executive officer owned 3,038,385 shares of the company’s stock, valued at $28,439,283.60. This trade represents a 4.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Price Performance

Shares of TRLV opened at $8.59 on Wednesday. Trulieve Cannabis Corp. has a 1-year low of $3.25 and a 1-year high of $13.28.

Analyst Upgrades and Downgrades

TRLV has been the topic of several research reports. Weiss Ratings began coverage on Trulieve Cannabis in a research report on Tuesday, June 16th. They set a “sell (d-)” rating on the stock. Zacks Research raised Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Reduce”.

About Trulieve Cannabis

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.